https://de.marketscreener.com/kurs/aktie/NEUMORA-THERAPEUTICS-INC-159308146/news/Neumoras-Studie-zu-Schizophrenie-Medikament-im-Fruhstadium-auf-Eis-gelegt-46434223/?utm_source=telegram&utm_medium=social&utm_campaign=share